FDA DEVICE FACTS
INNOVANCE® D-Dimer 2.0 (SMN 10873803)
Siemens Healthcare Diagnostic Products GmbH
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
INNOVANCE® D‑Dimer 2.0 is an in vitro diagnostic reagent for the quantitative, non-standardized determination of cross-linked fibrin degradation products (D-dimers). The INNOVANCE® D‑Dimer 2.0 reagent is intended for exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE) in conjunction with a clinical pretest probability (PTP) assessment model in outpatients suspected of DVT or PE in human sodium citrated plasma collected from venous blood samples in 3.2 % sodium citrate tubes. INNOVANCE® D‑Dimer 2.0 is for use on automated coagulation analyzers. (Comment: The intended use does not include an explicit statement regarding prescription use; instead, the product box label displays the symbol ‘RxOnly’ rather than the written phrase ‘and intended for prescription use’.)
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。